Related Experiment Video
Updated: Aug 6, 2026

Assessment of Mitochondrial Fission/Fusion Dynamics in Kidney Proximal Tubular Cells
Published on: November 14, 2025
Action of diclofenac on kidney mitochondria and cells
Lin Eng Ng1, Annette S Vincent, Barry Halliwell
1Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Kent Ridge, Singapore 119260, Singapore.
Abstract:
The mitochondrial membrane potential measured in isolated rat kidney mitochondria and in digitonin-permeabilized MDCK type II cells pre-energized with succinate, glutamate, and/or malate was reduced by micromolar diclofenac dose-dependently. However, ATP biosynthesis from glutamate/malate was significantly more compromised compared to that from succinate. Inhibition of the malate-aspartate shuttle by diclofenac with a resultant decrease in the ability of mitochondria to generate NAD(P)H was demonstrated. Diclofenac however had no effect on the activities of NADH dehydrogenase, glutamate dehydrogenase, and malate dehydrogenase. In conclusion, decreased NAD(P)H production due to an inhibition of the entry of malate and glutamate via the malate-aspartate shuttle explained the more pronounced decreased rate of ATP biosynthesis from glutamate and malate by diclofenac. This drug, therefore affects the bioavailability of two major respiratory complex I substrates which would normally contribute substantially to supplying the reducing equivalents for mitochondrial electron transport for generation of ATP in the renal cell.
Insights
Diclofenac impairs kidney cell energy production by disrupting the malate-aspartate shuttle, significantly reducing ATP synthesis from key substrates. This affects mitochondrial function and cellular energy supply.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Mitochondria are crucial for cellular energy production.
- The malate-aspartate shuttle facilitates the transport of reducing equivalents into mitochondria.
- Diclofenac is a nonsteroidal anti-inflammatory drug with known cellular effects.
Purpose of the Study:
- To investigate the impact of diclofenac on mitochondrial membrane potential and ATP biosynthesis in renal cells.
- To elucidate the mechanism by which diclofenac affects mitochondrial energy metabolism.
- To determine the effect of diclofenac on the malate-aspartate shuttle.
Main Methods:
- Measurement of mitochondrial membrane potential in isolated rat kidney mitochondria and digitonin-permeabilized MDCK cells.
- Assessment of ATP biosynthesis using succinate, glutamate, and malate as substrates.
- Enzyme activity assays for NADH dehydrogenase, glutamate dehydrogenase, and malate dehydrogenase.
- Evaluation of NAD(P)H generation and malate-aspartate shuttle function.
Main Results:
- Diclofenac dose-dependently reduced mitochondrial membrane potential.
- ATP biosynthesis from glutamate/malate was more compromised than from succinate.
- Diclofenac inhibited the malate-aspartate shuttle, decreasing NAD(P)H generation.
- Diclofenac did not affect the activity of key mitochondrial enzymes like NADH dehydrogenase.
Conclusions:
- Diclofenac impairs renal cell ATP production by inhibiting the malate-aspartate shuttle.
- This inhibition reduces the availability of essential substrates for mitochondrial electron transport.
- Diclofenac's effects on the malate-aspartate shuttle impact cellular energy homeostasis in the kidney.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Bioactivation and Tissue Toxicity
